Correction to: Oncogene (2008) 27, 6571–6580; doi:10.1038/onc.2008.249
Following the publication of this paper, the authors noted some errors in the figures presented.
The authors repeated the experiments presented in Figure 5c (western blot to show cytochrome c release upon PRIMA-1MET treatment) and Supplementary Figure S2 (western blot to show Bid cleavage upon PRIMA-1MET treatment) with small modifications. In Figure 5c, the pan-caspase inhibitor zVAD was used instead of the caspase-3 inhibitor zDEVD. In Supplementary Figure S2, an antibody that detects full-length Bid was used rather than an antibody that detects both full-length and cleaved Bid.
In addition, a new version of Figure 6a (siRNA knockdown of caspase-2) was created using raw data.
The three revised figures are presented below along with figure legends.
All data are in agreement with previous findings described in the original article, and the main conclusion remains unchanged.
The authors apologise for any inconvenience caused.
Additional information
The online version of the original article can be found at 10.1038/onc.2008.249
Supplementary information
Rights and permissions
About this article
Cite this article
Shen, J., Vakifahmetoglu, H., Stridh, H. et al. Erratum: PRIMA-1Met induces mitochondrial apoptosis through activation of caspase-2. Oncogene 35, 6446 (2016). https://doi.org/10.1038/onc.2016.210
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2016.210